Related references
Note: Only part of the references are listed.Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
Nick Bansback et al.
BMC NEUROLOGY (2019)
Developing quality criteria for patient-directed knowledge tools related to clinical practice guidelines. A development and consensus study
Trudy van der Weijden et al.
HEALTH EXPECTATIONS (2019)
Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling
Ingrid E. H. Kremer et al.
HEALTH EXPECTATIONS (2018)
Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
Dayo Afolabi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
Dayo Afolabi et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
Alexander Rae-Grant et al.
NEUROLOGY (2018)
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis
Marita Zimmermann et al.
CNS DRUGS (2018)
Information provision for people with multiple sclerosis
Sascha Koepke et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Gabriel Pardo et al.
JOURNAL OF NEUROLOGY (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
New insights into the burden and costs of multiple sclerosis in Europe
Gisela Kobelt et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Decision aids for people facing health treatment or screening decisions
Dawn Stacey et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
Peter Joseph Jongen
CNS DRUGS (2017)
Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling
Ingrid E. H. Kremer et al.
PLOS ONE (2016)
Multiple Criteria Decision Analysis for Health Care Decision Making-Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
Kevin Marsh et al.
VALUE IN HEALTH (2016)
Multiple Criteria Decision Analysis for Health Care Decision Making-An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
Praveen Thokala et al.
VALUE IN HEALTH (2016)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis A Randomized Clinical Trial
Jeffrey Cohen et al.
JAMA NEUROLOGY (2015)
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Towards generic online multicriteria decision support in patient-centred health care
Jack Dowie et al.
HEALTH EXPECTATIONS (2015)
User-centered design and the development of patient decision aids: protocol for a systematic review
Holly O. Witteman et al.
SYSTEMATIC REVIEWS (2015)
Network meta-analysis-highly attractive but more methodological research is needed
Tianjing Li et al.
BMC MEDICINE (2011)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ISRCTN25267500: Informed Shared Decision Making In Multiple Sclerosis Immunotherapy (ISDIMS). A randomised controlled trial to investigate the effects of an evidence-based decision aid on decision-making about immunotherapy in multiple sclerosis
J. Kasper et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Developing a quality criteria framework for patient decision aids: online international Delphi consensus process
Glyn Elwyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles
A Riazi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Patient preferences regarding antiretroviral therapy
LG Miller et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2002)
Share Paper
